Acute myeloid leukemia

Impact of upfront chemotherapy on overall survival in isolated myeloid sarcoma

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Overall survival of patients with isolated myeloid sarcoma according to the upfront treatment.

References

  1. 1.

    Swerdlow SCE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO classification of tumours of haematopoietic and lymphoid tissues (revised 4th edition). Lyon: IARC; 2017.

  2. 2.

    Dalland JC, Meyer R, Ketterling RP, Reichard KK. Myeloid sarcoma with CBFB-MYH11 Fusion (inv(16) or t(16;16)) prevails in the abdomen. Am J Clin Pathol. 2020;153:333–41.

    CAS  PubMed  Google Scholar 

  3. 3.

    Claerhout H, Van Aelst S, Melis C, Tousseyn T, Gheysens O, Vandenberghe P, et al. Clinicopathological characteristics of de novo and secondary myeloid sarcoma: a monocentric retrospective study. Eur J Haematol. 2018;100:603–12.

    CAS  Article  Google Scholar 

  4. 4.

    National Comprehensive Cancer Network. Acute myeloid leukemia (version 3.2020). National Comprehensive Cancer Network. 2019; https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf.

  5. 5.

    Walter RB, Othus M, Borthakur G, Ravandi F, Cortes JE, Pierce SA, et al. Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. J Clin Oncol. 2011;29:4417–23.

    Article  Google Scholar 

  6. 6.

    Putter H, van Houwelingen HC. Understanding landmarking and its relation with time-dependent Cox regression. Stat Biosci. 2017;9:489–503.

    Article  Google Scholar 

  7. 7.

    Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer. 2002;94:1739–46.

    Article  Google Scholar 

  8. 8.

    Byrne MM, Halman LJ, Koniaris LG, Cassileth PA, Rosenblatt JD, Cheung MC. Effects of poverty and race on outcomes in acute myeloid leukemia. Am J Clin Oncol. 2011;34:297–304.

    Article  Google Scholar 

  9. 9.

    Cole SR, Hernan MA. Adjusted survival curves with inverse probability weights. Comput Methods Prog Biomed. 2004;75:45–9.

    Article  Google Scholar 

  10. 10.

    Xie J, Liu C. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Stat Med. 2005;24:3089–110.

    Article  Google Scholar 

  11. 11.

    Lin DWLJ. The robust inference for the proportional hazards model. J Am Stat Assoc. 1989;84:1074–8.

    Article  Google Scholar 

  12. 12.

    VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167:268–74.

    Article  Google Scholar 

  13. 13.

    Imrie KR, Kovacs MJ, Selby D, Lipton J, Patterson BJ, Pantalony D, et al. Isolated chloroma: the effect of early antileukemic therapy. Ann Intern Med. 1995;123:351–3.

    CAS  Article  Google Scholar 

  14. 14.

    Goyal G, Bartley AC, Patnaik MM, Litzow MR, Al-Kali A, Go RS. Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set. Blood Cancer J. 2017;7:e592.

    CAS  Article  Google Scholar 

  15. 15.

    Tsimberidou AM, Kantarjian HM, Estey E, Cortes JE, Verstovsek S, Faderl S, et al. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia. 2003;17:1100–3.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Michael Boyiadzis.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lontos, K., Yabes, J.G., Farah, R.J. et al. Impact of upfront chemotherapy on overall survival in isolated myeloid sarcoma. Leukemia (2020). https://doi.org/10.1038/s41375-020-01017-z

Download citation

Search